As of Oct 12, 2026 close
- Market cap
- $7.32B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $50.56$392.70
- Volume (live)
- -
- Avg. volume (3M)
- 440.97K
Praxis Precision Medicines (PRAX) Stock Price & Financial Analysis
Praxis Precision Medicines Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $251.21 - $259.50 |
|---|---|
| 52-Week High | $392.70 |
| 52-Week Low | $50.56 |
| Open | $257.94 |
| Volume (last close) | 300.84K |
| Average Volume (3M) | 440.97K |
| Market Cap | 7.32B |
|---|---|
| Shares Outstanding | 29.13M |
| Price to Book (P/B) | 5.46 |
| EV/EBITDA | -19.94 |
| 50-Day MA | $328.52 |
|---|---|
| 200-Day MA | $316.57 |
| 1-Year Change | +380.28% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Praxis Precision Medicines at a Glance
Praxis Precision Medicines (PRAX) has a market capitalization of $7.32B. Revenue fell 100.0% year over year.
It holds $474.76M in cash and securities against $1.09M of debt, a net cash position of $473.67M.
Praxis Precision Medicines does not currently pay a dividend.
The share price is up 380.3% over the past year. At $251.38 it sits within its 52-week range of $50.56 to $392.70, below its 200-day moving average of $316.57.
Based on 16 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $702.07, 179.3% above the latest close.
Frequently Asked Questions About Praxis Precision Medicines
What is the current stock price for PRAX?
As of the Oct 12, 2026 close, PRAX stock trades at $251.38. The 52-week range is $50.56–$392.70, with a day range of $251.21–$259.50.
What is the P/E ratio for PRAX?
The P/E ratio (Price-to-Earnings) for PRAX is shown in the Key Statistics section. This valuation metric helps compare Praxis Precision Medicines, Inc. to industry peers.
Does PRAX pay dividends?
Praxis Precision Medicines does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for PRAX?
Based on 16 analysts, the consensus for PRAX is Buy.
What is the market cap of PRAX?
Praxis Precision Medicines's market capitalization is $7.32B, classifying it as a mid-cap company. Praxis Precision Medicines operates in the Healthcare sector within the Biotechnology industry.